Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 7/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.42 |
| ▸ | TACR2 | P21452 | 2/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SHBG | P04278 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL106928 | 1.00 | ESR1 (0.44) | ESR1ESR2IDO1MAOBADRA2A | |
| SCHEMBL448421 | 0.88 | ESR1 (0.55) | ESR1ESR2IDO1MAOBADRA2A | |
| SCHEMBL448422 | 0.88 | ESR1 (0.55) | ESR1ESR2IDO1MAOBADRA2A | |
| SCHEMBL3920909 | 0.83 | ESR1 (0.44) | ESR1ESR2IDO1MAOBADRA2A | |
| SCHEMBL3920915 | 0.83 | ESR1 (0.44) | ESR1ESR2IDO1MAOBADRA2A | |
| SCHEMBL3779173 | 0.79 | ESR1 (0.50) | ESR1ESR2ADRA2AADORA3TACR2 | |
| SCHEMBL3779170 | 0.79 | ESR1 (0.50) | ESR1ESR2ADRA2AADORA3TACR2 | |
| SCHEMBL1051791 | 0.79 | MAOB (0.44) | IDO1MAOBALDH1A1TP53CHRM2 | |
| SCHEMBL111719 | 0.79 | IDO1 (0.50) | ESR1ESR2IDO1ADRA2AADORA3 | |
| SCHEMBL156250 | 0.79 | MAOB (0.71) | ESR1ESR2IDO1MAOBSLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2463374-A2 | Isolated alcohol dehydrogenase enzymes and uses thereof | Bio Architecture Lab, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| US-20090155873-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-18 | — | — | US | claimed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | claimed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| US-7285688-B2 | Proton type β zeolite, preparation method thereof and process for preparing phenol compound using the same | UBE INDUSTRIES, LTD. (JP) | 2007-10-23 | — | — | US | claimed |
| JP-61293366-A | — | — | None | — | — | JP | disclosed |
| JP-61293367-A | — | — | None | — | — | JP | disclosed |
| EP-3230463-B2 | RAPID PRETREATMENT | APALTA PATENTS OUE (EE) | 2025-07-16 | — | — | EP | disclosed |
| US-20240425893-A1 | RAPID PRETREATMENT | Apalta Patents OÜ (EE) | 2024-12-26 | — | — | US | disclosed |
| US-12054761-B2 | Rapid pretreatment | Apalta Patents OÜ (EE) | 2024-08-06 | — | — | US | disclosed |
| CN-115286488-B | Method for extracting m-p-ethyl phenol and industrial xylenol from mixed xylenol | 煤炭科学技术研究院有限公司 | 2024-04-05 | — | — | CN | disclosed |
| US-11821047-B2 | High pressure zone formation for pretreatment | Apalta Patent OÜ (EE) | 2023-11-21 | — | — | US | disclosed |
| JP-S61293367-A | PRODUCTION OF MUSHROOM-LIKE FLAVOR | T HASEGAWA CO LTD | 1986-12-24 | — | — | JP | disclosed |
| JP-S61293366-A | MUSHROOM FLAVOR COMPOSITION | T HASEGAWA CO LTD | 1986-12-24 | — | — | JP | disclosed |
| US-4101675-A | ANTIHYPERTENSIVES | AKZONA INCORPORATED (US) | 1978-07-18 | — | — | US | disclosed |
| US-4078006-A | HYDROGEN PEROXIDE OXIDATION | UBE INDUSTRIES, LTD. (JA) | 1978-03-07 | — | — | US | disclosed |
| US-4072722-A | OXIDIZING A MONOHYDRIC PHENOL WITH A KETONE PEROXIDE | UBE INDUSTRIES, LTD. (JA) | 1978-02-07 | — | — | US | disclosed |
| US-4013727-A | OXIDATION OF PHENYL ETHERS WITH HYDROGEN PEROXIDE | UBE INDUSTRIES, LTD. (JA) | 1977-03-22 | — | — | US | disclosed |
| US-3972932-A | Novel 2,6-disubstituted phenyl-aminoguanidine compounds | AKZONA INCORPORATED (US) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090139134-A1 | BIOFUEL PRODUCTION | MGAM, DCXR, MANBA | ESR1 3581/4885ESR2 3683/4885IDO1 2541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.